phase 1/2 study results of liposomal irinotecan and folfox in pancreatic cancer
Published 4 years ago • 638 plays • Length 8:07Download video MP4
Download video MP3
Similar videos
-
4:48
liposomal irinotecan in advanced pancreatic cancer
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
3:54
impact of second-line approval of liposomal irinotecan
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
6:47
pancreatic cancer: data with liposomal irinotecan/5-fu
-
4:24
nifty: liposomal irinotecan in combination with 5fu and leucovorin in patients with mbtc
-
1:43
liposomal irinotecan fluorouracil/leucovorin after progression in mpdac
-
2:41
liposomal irinotecan plus 5-fu & leucovorin for patients with metastatic btc
-
7:24
pancreas cancer: incorporating nanoliposomal irinotecan
-
5:39
the napoli-1 trial in pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
4:22
mm-398 for second-line therapy in advanced pancreatic cancer
-
0:40
1l nalirifox in advanced or metastatic pdac
-
0:55
robin brenner on side effects of onivyde for pancreatic cancer
-
9:08
folfirinox in metastatic pancreatic cancer
-
3:27
second-line pancreatic cancer: nanoliposomal irinotecan
-
6:20
first-line nalirifox shows improvement in os and pfs in metastatic pancreatic cancer
-
5:03
sequencing decisions in advanced pancreatic cancer